No Data
TD Cowen Initiates Cartesian Therapeutics(RNAC.US) With Buy Rating
TD Cowen analyst Tyler Van Buren initiates coverage on $Cartesian Therapeutics(RNAC.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 44.0% and a total average
Cartesian Therapeutics Analyst Ratings
Express News | Cartesian Therapeutics Inc : TD Cowen Initiates Coverage With Buy Rating
Express News | Cartesian Therapeutics Inc Files for Resale of up to 6.5 Mln Shares by Selling Stockholders - SEC Filing
Russell 2000 Rise: Top 5 Best, Worst Performers During July's Rally in Small-cap Stocks
Cartesian Therapeutics Announces New Employment Inducement Grants